UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications

Frontiers in physiology, 2018-02, Vol.9, p.114-114

2018

Volltextzugriff (PDF)

Recent novel approaches to limit oxidative stress and inflammation in diabetic complications

Clinical & translational immunology, 2018, Vol.7 (4), p.e1016-n/a

2018

Volltextzugriff (PDF)

Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease

Diabetes (New York, N.Y.), 2014-09, Vol.63 (9), p.3091-3103

2014

Volltextzugriff (PDF)

Direct Endothelial Nitric Oxide Synthase Activation Provides Atheroprotection in Diabetes-Accelerated Atherosclerosis

Diabetes (New York, N.Y.), 2015-11, Vol.64 (11), p.3937-3950

2015

Volltextzugriff (PDF)

The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction

Cardiovascular diabetology, 2017-03, Vol.16 (1), p.33-33, Article 33

2017

Volltextzugriff (PDF)

Are reactive oxygen species still the basis for diabetic complications?

Clinical science (1979), 2015-07, Vol.129 (2), p.199-216

2015

Volltextzugriff (PDF)

Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice

Atherosclerosis, 2015-12, Vol.243 (2), p.598-608

2015

Volltextzugriff (PDF)

Deciphering the Binding of Caveolin-1 to Client Protein Endothelial Nitric-oxide Synthase (eNOS)

The Journal of biological chemistry, 2014-05, Vol.289 (19), p.13273-13283

2014

Volltextzugriff (PDF)

Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities

Scientific reports, 2023-05, Vol.13 (1), p.8741-8741

2023

Volltextzugriff (PDF)

Myoferlin is critical for endocytosis in endothelial cells

American Journal of Physiology: Cell Physiology, 2009-09, Vol.297 (3), p.C484-C492

2009

Volltextzugriff (PDF)

SOD2 in skeletal muscle: New insights from an inducible deletion model

Redox biology, 2021-11, Vol.47, p.102135-102135, Article 102135

2021

Volltextzugriff (PDF)

Editorial: Translational Approaches for Targeting Cardiovascular Complications of Diabetes

Frontiers in pharmacology, 2021-11, Vol.12, p.799020-799020

2021

Volltextzugriff (PDF)

Characterising an Alternative Murine Model of Diabetic Cardiomyopathy

Frontiers in physiology, 2019-11, Vol.10, p.1395-1395

2019

Volltextzugriff (PDF)

The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice

PloS one, 2013-07, Vol.8 (7), p.e69193-e69193

2013

Volltextzugriff (PDF)

NFκB Inhibition Mitigates Serum Amyloid A-Induced Pro-Atherogenic Responses in Endothelial Cells and Leukocyte Adhesion and Adverse Changes to Endothelium Function in Isolated Aorta

International journal of molecular sciences, 2018-12, Vol.20 (1), p.105

2018

Volltextzugriff (PDF)

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase

Frontiers in cardiovascular medicine, 2023-07, Vol.10, p.1220095-1220095

2023

Volltextzugriff (PDF)

Targeting Endothelial Dysfunction in Vascular Complications Associated with Diabetes

International Journal of Vascular Medicine, 2012-01, Vol.2012 (2012), p.346-357

2012

Volltextzugriff (PDF)

Serum Amyloid A Stimulates Vascular and Renal Dysfunction in Apolipoprotein E-Deficient Mice Fed a Normal Chow Diet

Frontiers in immunology, 2019-03, Vol.10, p.380-380

2019

Volltextzugriff (PDF)

Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy

Frontiers in physiology, 2021-08, Vol.12, p.734320-734320

2021

Volltextzugriff (PDF)

Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1

European journal of pharmacology, 2011-06, Vol.659 (2), p.206-212

2011

Volltextzugriff (PDF)

Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis

Diabetes (New York, N.Y.), 2021-03, Vol.70 (3), p.772-787

2021

Volltextzugriff (PDF)

New insights into caveolae, caveolins and endothelial function

Canadian journal of cardiology, 2010-03, Vol.26, p.5A-8A

2010

Volltextzugriff (PDF)

Animal models of diabetes‐associated vascular diseases: an update on available models and experimental analysis

British journal of pharmacology, 2022-03, Vol.179 (5), p.748-769

2022

Volltextzugriff (PDF)

A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice

The Journal of clinical investigation, 2011-09, Vol.121 (9), p.3747-3755

2011

Volltextzugriff (PDF)

Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease

Clinical science (1979), 2022-01, Vol.136 (2), p.167-180

2022

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications

Recent novel approaches to limit oxidative stress and inflammation in diabetic complications

Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease

Direct Endothelial Nitric Oxide Synthase Activation Provides Atheroprotection in Diabetes-Accelerated Atherosclerosis

The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction

Are reactive oxygen species still the basis for diabetic complications?

Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice

Deciphering the Binding of Caveolin-1 to Client Protein Endothelial Nitric-oxide Synthase (eNOS)

Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities

Myoferlin is critical for endocytosis in endothelial cells

SOD2 in skeletal muscle: New insights from an inducible deletion model

Editorial: Translational Approaches for Targeting Cardiovascular Complications of Diabetes

Characterising an Alternative Murine Model of Diabetic Cardiomyopathy

The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice

NFκB Inhibition Mitigates Serum Amyloid A-Induced Pro-Atherogenic Responses in Endothelial Cells and Leukocyte Adhesion and Adverse Changes to Endothelium Function in Isolated Aorta

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase

Targeting Endothelial Dysfunction in Vascular Complications Associated with Diabetes

Serum Amyloid A Stimulates Vascular and Renal Dysfunction in Apolipoprotein E-Deficient Mice Fed a Normal Chow Diet

Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy

Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1

Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis

New insights into caveolae, caveolins and endothelial function

Animal models of diabetes‐associated vascular diseases: an update on available models and experimental analysis

A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice

Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease

Suchergebnisse filtern